The Phase II study was designed to compare the safety, tolerability and pharmacokinetic profiles of the PG-fre...
You must be logged in to view the whole article.
Click here if you require signing up
FDA gives orphan drug designation to Telik’s myelodysplastic syndrome product
GeoVax Labs completes enrolment of nine patients in Phase 1/2 trial of DNA/MVA vaccine
Evotec reaches drug discovery collaboration with Ono Pharmaceutical
CECOG reports positive results from combination therapy in breast cancer
Bioiberica to develop cartilage regeneration therapy - report
Qualyst Transporter Solutions launches Bilirubin contract research service
NTRR’s new supplement designed to tackle erectile dysfunction
FDA lifts partial clinical hold on Idenix's HCV nucleotide inhibitor IDX184